TNBC tissues; adjacent normal tissues; tumor tissues; lung tissues
MCF-10A; MCF-7; T47D; MDA-MB-468; MDA-MB-231; BT549; HCC1954; HEK293T
cell line-derived xenograft
ceRNA regulation (other); proliferation (promotes); cell cycle (promotes); migration (promotes); invasion (promotes); metastasis (promotes); angiogenesis (promotes); p53 signaling (inhibits); ubiquitination (promotes)
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Northern Blot; FISH / smFISH; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; ChIP / ChIP-seq; Luciferase Reporter Assay; Transfection; EdU Staining; Colony Formation Assay; Cell Cycle Assay; Transwell Assay; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Western Blot; Cohort Study; Survival Analysis; Bioinformatics Analysis
High circ_0004674 expression correlates with tumor volume, lymph node metastasis, distant metastasis, TNM terminal stage, and poor OS and DFS in TNBC patients.
This study reports that circ_0004674 is up-regulated in TNBC tissues and cell lines and that high expression predicts poor OS and DFS. Functionally, circ_0004674 promotes TNBC proliferation, cell cycle progression, migration, invasion, tumor growth, and metastasis. Mechanistically, it acts as a miR-377-3p sponge to increase E2F6 and downstream PNO1 expression, promoting p53 ubiquitination/degradation and TNBC progression.
0.8867
Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis.
combined biological and clinical study